THE PROTECT STUDY: EVEROLIMUS MONOTHERAPY vs. CALCINEURIN INHIBITOR-BASED THERAPY RESULTS IN PROGRESSIVE RENAL FUNCTION BENEFIT OVER 35 MONTHS IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Sterneck, M. [1 ]
Kaiser, G. [2 ]
Richter, N. [3 ]
Heyne, N. [4 ]
Rauchfuss, F. [5 ]
Neuhaus, P. [6 ]
Schemmer, P. [7 ]
Fischer, L. [1 ]
Paulus, E. M. [8 ]
Mertens, M. [8 ]
Schlitt, H. J. [9 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany
[2] Essen Univ Hosp, Dept Gen Visceral & Transplantat Surg, Essen, Germany
[3] Hannover Med Sch MHH, Clin Gen Abdominal & Transplant Surg, Hannover, Germany
[4] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany
[5] Jena Univ Hosp, Dept Gen Abdominal & Vasc Surg, Jena, Germany
[6] Charite Univ Med Ctr Berlin, Clin Gen Adbominal & Transplant Surg, Berlin, Germany
[7] Univ Heidelberg Hosp, Dept Gen Visceral & Transplant Surg, Heidelberg, Germany
[8] Novartis Pharmaceut, Nurnberg, Germany
[9] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60187-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
185
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] The PROTECT study: Renal function benefit with everolimus versus calcineurin inhibitor-based therapy was maintained over 35 months in liver transplant recipients
    Schlitt, Hans J.
    Kaiser, Gernot M.
    Richter, Nicolas
    Heyne, Nils
    Rauchfuss, Falk
    Neuhaus, Peter
    Schemmer, Peter
    Fischer, Lutz
    Paulus, Eva-Maria
    Mertens, Michael
    Sterneck, Martina
    [J]. HEPATOLOGY, 2012, 56 (06) : 1531 - 1532
  • [2] The PROTECT Study: Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy over 35 Months Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients.
    Schlitt, H. J.
    Kaiser, G.
    Richter, N.
    Heyne, N.
    Rauchfuss, F.
    Schemmee, P.
    Fischer, L.
    Paulus, E. -M.
    Mertens, M.
    Sterneck, M.
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S88 - S88
  • [3] THE PROTECT STUDY: EFFECT OF 35 MONTH EVEROLIMUS MONOTHERAPY VS. CALCINEURIN INHIBITOR-BASED THERAPY ON EFFICACY AND RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS
    Schlitt, H.
    Kaiser, G.
    Richter, N.
    Heyne, N.
    Rauchfuss, F.
    Pascher, A.
    Schemmer, P.
    Fischer, L.
    Paulus, E.
    Mertens, M.
    Sterneck, M.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
  • [4] The PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients.
    Schlitt, H.
    Kaiser, G.
    Richter, N.
    Heyne, N.
    Rauchfuss, F.
    Neuhaus, P.
    Schemmer, P.
    Fischer, L.
    Paulus, E.
    Mertens, M.
    Sterneck, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 130 - 130
  • [5] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
  • [6] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients
    Budde, K.
    Zeier, M.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. M.
    Pietruck, F.
    Reinke, P.
    Rath, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 504 - 504
  • [7] THE PROTECT STUDY: SUSTAINED SUPERIOR RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS AFTER 35 MONTHS
    Sterneck, Martina
    Kaiser, Gernaud
    Richter, Nicolas
    Heyne, Nils
    Rauchfuss, Falk
    Schemmer, Peter
    Fischer, Lutz
    Paulus, Eva-Maria
    Mertens, Michael
    Schlitt, Hans-Juergen
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [8] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [9] Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in De Novo Liver Transplant Recipients Preserves Renal Function
    Montalti, Roberto
    Rompianesi, Gianluca
    Di Benedetto, Fabrizio
    Codeluppi, Mauro
    Cautero, Nicola
    Guerrini, Gian Piero
    Smerieri, Nazareno
    Serra, Valentina
    Iemmolo, Rosa Maria
    Marino, Maria
    De Pietri, Lesley
    Gerunda, Giorgio Enrico
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S134 - S134
  • [10] Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
    Masetti, M.
    Montalti, R.
    Rompianesi, G.
    Codeluppi, M.
    Gerring, R.
    Romano, A.
    Begliomini, B.
    Di Benedetto, F.
    Gerunda, G. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (10) : 2252 - 2262
12345